Companies · Healthtech

Aqueduct Critical Care, Inc.

BOTHELL · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on Aqueduct Critical Care, Inc. — recommendation, valuation, rhythm, risks.
$10.3M
Total raised · real
4
Rounds
1.3×
Latest step-up
Top 31%
Sector rank · raised
Series A
Latest stage · inferred · Wed Jun 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Aqueduct Critical Care, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.14× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Aqueduct Critical Care, Inc. is one of 2138 Healthtech companies tracked from BOTHELL. By capital raised it ranks in the upper tier (ahead of 70% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2013
Year incorporated
2018-06-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2015-08-18 Raised $6.8M (real) Modeled valuation $153M (est)$6.8M$153MSeries A2015Seed · 2015-08-18 Raised $3.7M (real) Modeled valuation $103M (est)$3.7M$103MSeed2015Series A · 2016-12-21 Raised $2.0M (real) Modeled valuation $45M (est)$2.0M$45MSeries A2016Series A · 2017-08-24 Raised $640K (real) Modeled valuation $14M (est)$640K$14MSeries A2017Series A · 2018-06-13 Raised $822K (real) Modeled valuation $19M (est)$822K$19MSeries A2018+$3.7M+$2.0M+$640K+$822KCumulative $14M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.8M · 2015
Bridge · Series A-stage$3.7M · 2015smaller follow-on
Series A extension$2.0M · 2016
Series A extension$640K · 2017
Series A extension$822K · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$18.5M
Base estimate est.
$1.1M
Conservative case
$100.8M
Upside case
$3.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $153.0M · 2015-08-182015Seed · modeled $102.9M · 2015-08-18Series A · modeled $45.4M · 2016-12-21Series A · modeled $14.4M · 2017-08-24Series A · modeled $18.5M · 2018-06-132018
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
6.0 yr
Elapsed time used
8.1 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$3.6M/yr
Capital velocity
10.9 yr
On record since
2015
First round
5
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.3× above median
This company$10.3M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$822K
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$18.5M
Sector median$33.8M

Raised more than 70% of sector peers (real $). Modeled value above 43% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #98 of 103.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Prenexus Health, LLC · Series A Raised $30.0M · modeled $338.6M (est)HealthMyne, Inc. · Series A Raised $21.9M · modeled $338.6M (est)Companion Medical, Inc. · Series A Raised $20.5M · modeled $318.6M (est)Health at Scale Corp · Series A Raised $14.0M · modeled $316.0M (est)Motus GI Medical Technologies, Ltd. · Series A Raised $13.8M · modeled $310.8M (est)Cohero Health, Inc. · Series A Raised $13.3M · modeled $301.3M (est)Apama Medical, Inc. · Series A Raised $14.3M · modeled $297.4M (est)Parsley Health, Inc. · Series A Raised $14.5M · modeled $289.1M (est)Trilliant Health, Inc. · Series A Raised $12.7M · modeled $285.9M (est)Dental Whale, LLC · Series A Raised $12.5M · modeled $282.2M (est)Livestock Health Solutions, LLC · Series A Raised $12.0M · modeled $270.9M (est)Scottline Healthcare Solutions, Inc. · Series A Raised $12.0M · modeled $270.9M (est)Aqueduct Critical Care, Inc. (this company) Raised $10.3M · modeled $18.5M (est)Aqueduct Critical Care, Inc.
CompanyStageRaised · realValue · estvs peer med.
Prenexus Health, LLCSeries A$30.0M$338.6M2.53×
HealthMyne, Inc.Series A$21.9M$338.6M2.53×
Companion Medical, Inc.Series A$20.5M$318.6M2.38×
Health at Scale CorpSeries A$14.0M$316.0M2.36×
Motus GI Medical Technologies, Ltd.Series A$13.8M$310.8M2.33×
Cohero Health, Inc.Series A$13.3M$301.3M2.25×
Apama Medical, Inc.Series A$14.3M$297.4M2.23×
Parsley Health, Inc.Series A$14.5M$289.1M2.16×
Trilliant Health, Inc.Series A$12.7M$285.9M2.14×
Dental Whale, LLCSeries A$12.5M$282.2M2.11×
Livestock Health Solutions, LLCSeries A$12.0M$270.9M2.03×
Scottline Healthcare Solutions, Inc.Series A$12.0M$270.9M2.03×
Aqueduct Critical Care, Inc. this companySeries A$10.3M$18.5M0.14×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.8M2015-08-18$30.8M$153.0M85%
Seed$3.7M2015-08-18$18.6M$102.9M85%
Series A$2.0M2016-12-21$9.1M$45.4M90%
Series A$640K2017-08-24$2.9M$14.4M90%
Series A$822K2018-06-13$3.7M$18.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.8M2015-08-18
    • First recorded raise — entered as Series A.
    • 100 investors on this round.
  2. Seed$3.7M2015-08-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 74 investors on this round.
  3. Series A$2.0M2016-12-21
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 24 investors on this round.
  4. Series A$640K2017-08-24
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 3.1× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  5. Series A$822K2018-06-13
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 7 investors on this round.
Intelligence
2019 ~Q1
Modeled next raise · ~8mo cadence
$1.1M
Modeled next size est.range $822K$1.7M
1.3×
Last step-up
$3.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Samuel R. Browd2 other2015-08
Eric R. Bell1 other2018-06
Thomas Clement1 other2015-08
Ky R. Calder2015-08
Richard R. Wohns2015-08
Susan R. Preston2015-08
Registry & provenance

Aqueduct Critical Care, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1651487
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Greenlight Health Data Solutions, Inc.HealthtechSeries A$10.2M$17.8Msame sector · same stage
Clozex Medical, Inc.HealthtechSeries A$10.4M$19.3Msame sector · same stage
Cordata Healthcare Innovations, Inc.HealthtechSeries A$10.5M$14.6Msame sector · same stage
Psyched Wellness Ltd.HealthtechSeries A$10.8M$13.6Msame sector · same stage
Child Health Imprints (CHIL) USA, Inc.HealthtechSeries A$9.7M$21.7Msame sector · same stage
Visible Health Inc.HealthtechSeries A$9.7M$27.6Msame sector · same stage
Imricor Medical Systems IncHealthtechSeries A$11.0M$13.8Msame sector · same stage
Banjo Health Inc.HealthtechSeries A$9.6M$19.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Aqua Medical, Inc.HealthtechSeries A$153.8M82%
1 Health Providence, Inc.HealthtechPre-Seed$1.9M80%
Healthstream IncHealthtechSeed$9.6M79%
Vasoptic Medical, Inc.HealthtechSeed$43.0M79%
Clinical Cardiac IncHealthtechPre-Seed$12.1M79%
Roman Health Ventures Inc.HealthtechGrowth/Late$11.7B79%
Health Deck Technologies Inc.HealthtechPre-Seed$5.6M79%
Medical Engineering Innovations, Inc.HealthtechSeed$44.5M79%
Frequently asked
How much funding has Aqueduct Critical Care, Inc. raised?
Aqueduct Critical Care, Inc. has raised approximately $10.3M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Aqueduct Critical Care, Inc.'s estimated valuation?
Provath's modeled valuation for Aqueduct Critical Care, Inc. is approximately $18.5M (modeled range $1.1M–$100.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Aqueduct Critical Care, Inc. at?
Aqueduct Critical Care, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Jun 13.
What does Aqueduct Critical Care, Inc. do and where is it based?
Aqueduct Critical Care, Inc. operates in the Healthtech sector, based in BOTHELL.
Explore related

See where Aqueduct Critical Care, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Aqueduct Critical Care, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.